Search results (50)
« Back to NewsExpanding OxCITE: New funding to accelerate immunotherapy research
16 Sep, 2026
New funding from Cancer Research Horizons will help researchers to better understand why some patients respond well to immunotherapy while others do not.
Professor Marella de Bruijn receives MRC Programme Award
11 Sep, 2026
Congratulations to Professor de Bruijn, who has been awarded funding from the UKRI Medical Research Council to investigate how the first blood stem cells formed in the embryo acquire their exceptional regenerative potential, with the aim of informing future stem cell therapies.
Professor Bethan Psaila wins ISEH Janet Rowley Award
1 Sep, 2026
Congratulations to Professor Psaila, who has received the 2026 Janet Rowley Award from the International Society for Experimental Hematology, in recognition of her outstanding contributions in the field of experimental haematology.
Professor KJ Patel awarded Royal Society Buchanan Medal
1 Sep, 2026
Congratulations to Professor Patel, who has received the Buchanan Medal, which recognises distinguished contributions to the biomedical sciences.
MRC WIMM achieves Gold Green Impact award
3 Jul, 2026
Congratulations to the Institute's Green Impact team, who achieved Gold in the University of Oxford's 2026 Green Impact awards.
WIMM Day 2026: connecting people, ideas and scientific discovery
26 Jun, 2026
- Centre for Computational Biology
- Department of Oncology
- Grants & Awards
- MRC MHU
- MRC TIDU
- NDCN
- NDM
- NDWRH
- RDM
On Tuesday 23rd June, the MRC WIMM community came together at Saïd Business School for the Institute's annual away day, sharing research, professional achievements and much more.
Professor Jan Rehwinkel receives funding to tackle viral threats
25 Jun, 2026
A research project led by Professor Jan Rehwinkel is one of three innovative Oxford-led projects aimed at transforming how we protect against respiratory viruses, which have secured funding through the UK’s Advanced Research and Invention Agency (ARIA).
Professor KJ Patel awarded major European Research Council Advanced Grant
23 Jun, 2026
Professor Patel is one of fourteen researchers at the University of Oxford awarded Advanced Grants from the European Research Council (ERC), each worth up to €2.5 million over a period of five years.
Professor Adam Mead joins Oxford Cancer leadership team
15 Jun, 2026
Congratulations to Adam Mead, who has been appointed Director of Oxford Cancer. Professor Mead joins Professors Mark Middleton and Tim Elliott in leading Oxford’s interdisciplinary cancer research community.
Academy of Medical Sciences elects Professor Tao Dong as new Fellow
21 May, 2026
Congratulations to Tao Dong, who has been elected a Fellow of the Academy of Medical Sciences in recognition of her outstanding contributions to advancing medical science through discovery research, translational studies, and the application of scientific knowledge for patient and public benefit.
Deputy Directors of the MRC Weatherall Institute of Molecular Medicine
7 May, 2026
Professor Adam Mead is joining Professor Alison Simmons as a Deputy Director of the WIMM in May 2026.
Congratulations to our new Associate Professors
7 May, 2026
MRC WIMM is delighted to announce the conferment of two new Associate Professorships. Our newly appointed Associate Professors have been recognised for their outstanding contributions to research, teaching, and citizenship within the University and beyond.
Kevin Rue-Albrecht to lead BioFAIR Pathfinder Project
22 Apr, 2026
Congratulations to Dr Kevin Rue-Albrecht, who has been selected as one of BioFAIR’s inaugural Pathfinder Projects.
Pramila Rijal awarded grant from Academy of Medical Sciences Springboard Programme
15 Apr, 2026
Now in its 11th year, Springboard supports researchers at a critical point in their careers, when many are establishing laboratories for the first time and need the freedom to explore ambitious questions.
Onima Chowdhury receives Cancer Research UK clinical trial grant
8 Apr, 2026
Congratulations to Dr Onima Chowdhury, who has been awarded a clinical trial grant by Cancer Research UK to improve treatment of Myelodysplastic Syndromes.